SCHEMBL5837327

SCHEMBL5837327

CCn1c(=O)n(CC)c2cc(C(=O)OC)ccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
HPD P32754 8/20 0.54
ALDH1A1 P00352 3/20 0.51
MAPT P10636 2/20 0.51
GAA P10253 1/20 0.51
GFER P55789 1/20 0.51
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
ACSS2 Q9NR19 1/20 0.48
APOBEC3A P31941 1/20 0.48
APOBEC3G Q9HC16 1/20 0.48
CYP1A2 P05177 1/20 0.48
TSHR P16473 1/20 0.47
HSD17B10 Q99714 1/20 0.47
PTGER4 P35408 1/20 0.46
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
XDH P47989 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17434605 0.85 KMT2A (0.55) KDM4EHPDALDH1A1GAAMEN1
SCHEMBL474587 0.82 MAPT (0.48) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL6205386 0.82 HPD (0.58) KDM4EHPDALDH1A1MAPTGAA
SCHEMBL4282176 0.81 CNR2 (0.50) KDM4EHPDALDH1A1MAPTGAA
SCHEMBL18998076 0.78 MAPT (0.42) KDM4EHPDALDH1A1MAPTMEN1
SCHEMBL20529258 0.77 KMT2A (0.55) KDM4EALDH1A1MAPTGAAMEN1
SCHEMBL309049 0.77 KDM4E (0.41) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL29342927 0.76 KDM4E (0.59) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL7539164 0.76 SMN1; SMN2 (0.65) KDM4EALDH1A1MAPTGAAMEN1
SCHEMBL4728729 0.75 PTGER4 (0.69) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7056918-B2 Benzimidazole anti-inflammatory compounds PFIZER, INC. (US) 2006-06-06 US disclosed
US-20030092749-A1 Novel benzimidazole anti-inflammatory compounds PFIZER INC. 2003-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092749-A1 Novel benzimidazole anti-inflammatory compounds MAPK1, JAK1, CNKSR1 KDM4E 4128/4885HPD 4598/4885ALDH1A1 1806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.